FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 5170094 · Received October 23, 2015

Report

Report Number
3004464228-2015-01316
Event Type
Malfunction
Date Received
October 23, 2015
Date of Event
September 27, 2015
Report Date
September 27, 2015
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K122953
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE RETURNED PRODUCT WAS EVALUATED AND THE REPORTED NEEDLE MECHANISM FAILURE WAS CONFIRMED. ITS ROOT CAUSE WAS DETERMINED TO BE THAT THE RELEASE BAR WAS INSTALLED INCORRECTLY.

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. WE ARE UNABLE TO CONFIRM THE REPORTED NEEDLE FAILED TO INSERT OR TO DETERMINE ITS ROOT CAUSE. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD USER GUIDE WARNS "CHECK THE INFUSION SITE AFTER INSERTION TO ENSURE THAT THE CANNULA WAS PROPERLY INSERTED. THE PDM WILL AUTOMATICALLY REMIND YOU TO CHECK YOUR BLOOD GLUCOSE 1.5 HOURS AFTER EACH POD CHANGE. IF THE CANNULA IS NOT PROPERLY INSERTED, HYPERGLYCEMIA MAY RESULT. VERIFY THERE IS NO WETNESS OR SCENT OF INSULIN, WHICH MAY INDICATE THE CANNULA HAS DISLODGED," AND "TEST RESULTS GREATER THAN 250 MG/DL MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). IF YOU GET RESULTS ABOVE 250 MG/DL, BUT DO NOT HAVE SYMPTOMS OF HYPERGLYCEMIA, REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL ABOVE 250 MG/DL, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER."

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT HER BLOOD GLUCOSE REACHED 478 MG/DL AFTER WEARING THE POD BETWEEN 4 AND 24 HOURS. THE POD WAS DEACTIVATED AND SHE NOTICED THE NEEDLE DID NOT PROPERLY INSERT THE CANNULA INTO THE SKIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
701634 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 14000 L41708

Patients

Seq Age Sex Outcome Treatment
1 65 YR